124750-51-2

Basic information

• Product Name: 5-(4'-Bromomethyl-1,1'-biphenyl-2-yl)-1-triphenylmethyl-1H-tetrazole
• Synonyms: N-(Triphenylmethyl)-5-(4'-bromomethylbiphenyl-2-yl-)terazole;N-(TRIPHENYLMETHYL)-5-(4'-BROMOMETHYLBIPHENYL-2-YL) TETRAZOLE;5-(4'-BROMOMETHYL-1,1'-BIPHENYL-2-YL)-1-TRIPHENYLMETHYL-1H-TETRAZOLE;5-(4'-BROMOMETHYL-BIPHENYL-2-YL)-1-TRITYL-1H-TETRAZOLE;1H-Tetrazole, 5-[4'-(bromomethyl)[1,1'-biphenyl]-2-yl]-1-(triphenylmethyl)-;Trityl tetrazole bromomethyl biphenyl;5-(4'-(BROMOMETHYL)(1,1'-BIPHENYL)-2-YL)-1-TRITYL-;5-[4'-(Bromomethyl)[1,1'-Biphenyl]-1-(Triphenylmethyl)Tetrazole]
• CAS NO: 124750-51-2
• Molecular Formula: C₃₃H₂₅BrN₄
• Molecular Weight: 557.48
• EINECS: 1592732-453-0
• Product Categories: INTERMEDIATESOF;Biphenyl & Diphenyl ether;Tetrazoles;API intermediates;(intermediates of candesartan cilexetil);Hypertension;Amines;Aromatics;Heterocycles;Intermediates
• Mol File: 124750-51-2.mol

Chemical Properties

• Melting Point: 152-155°C
• Boiling Point: 61°C/12mmHg(lit.)
• Flash Point: 388.299 °C
• Appearance: off-white solid
• Density: 1.282 g/cm³
• Storage Temp.: -20?C Freezer
• PKA: 0.29±0.10(Predicted)
• Stability: Moisture Sensitive
• CAS DataBase Reference: 5-(4'-Bromomethyl-1,1'-biphenyl-2-yl)-1-triphenylmethyl-1H-tetrazole(CAS DataBase Reference)
• NIST Chemistry Reference: 5-(4'-Bromomethyl-1,1'-biphenyl-2-yl)-1-triphenylmethyl-1H-tetrazole(124750-51-2)
• EPA Substance Registry System: 5-(4'-Bromomethyl-1,1'-biphenyl-2-yl)-1-triphenylmethyl-1H-tetrazole(124750-51-2)

Safety Data

• RIDADR: UN 2811 6.1/PG III
• HazardClass: 6.1
• PackingGroup: III
• Hazardous Substances Data: 124750-51-2(Hazardous Substances Data)

Synthetic route

N-triphenylmethyl-5-(4'-methylbiphenyl-2-yl)tetrazole (124750-53-4) → N-(triephenylmethyl)-5-<4'-(bromomethyl)-biphenyl-2-yl>tetrazole (124750-51-2)

Conditions	Yield
With bromine In hexane; water at 69℃; for 0.433333h; Temperature; Solvent; Irradiation; Flow reactor;	95.2%
With sodium bromate; sodium hydrogensulfite In water; 1,2-dichloro-ethane at 20℃; Product distribution / selectivity;	90%
With N-Bromosuccinimide; dihydrogen peroxide In dichloromethane Reflux;	88%

4'-hydroxymethyl-2-(N-trityl-1H-tetrazol-5-yl)biphenyl (154709-18-9) → N-(triephenylmethyl)-5-<4'-(bromomethyl)-biphenyl-2-yl>tetrazole (124750-51-2)

Conditions	Yield
With phosphorus tribromide In dichloromethane at 10 - 20℃; for 1h;	95.07%
With sulfuric acid; potassium bromide In N,N-dimethyl acetamide at 10 - 25℃; for 7h; Reagent/catalyst; Solvent;	81.4%

N-triphenylmethyl-5-(4'-methylbiphenyl-2-yl)tetrazole (124750-53-4) → N-(triephenylmethyl)-5-<4'-(bromomethyl)-biphenyl-2-yl>tetrazole (124750-51-2) + 5-(4'-Dibromomethyl-biphenyl-2-yl)-1-trityl-1H-tetrazole

Conditions	Yield
With N-Bromosuccinimide; 2,2'-azobis(isobutyronitrile); sodium acetate; acetic acid In dichloromethane for 16h; Heating;	A 76% B 7%
With 1,3-dibromo-5,5-dimethylimidazolidine-2,4-dione; 2,2'-azobis(isobutyronitrile) In chlorobenzene at 80℃; Overall yield = 78.6 %;

salicylonitrile (611-20-1) → N-(triephenylmethyl)-5-<4'-(bromomethyl)-biphenyl-2-yl>tetrazole (124750-51-2)

Conditions	Yield
Multi-step reaction with 4 steps 1: 98 percent / pyridine / 1.) 0 deg C, 5 min, 2.) r.t., 25 h 2: 1.) Mg, I2; n-Bu3SnCl, 2.) Pd(PPh3)2Cl2, LiCl / 1.) THF, reflux, 30 min; THF, reflux, 20 h, 2.) DMF, 98 deg C, 24 h 3: 1.) NaN3, n-Bu3SnCl, 2.) NaOH / 1.) toluene, 115 deg C, 70 h, 2.) toluene, r.t., 3 h 4: NBS, AIBN / CCl4 / 3 h / Heating View Scheme

4-tolyl iodide (624-31-7) → N-(triephenylmethyl)-5-<4'-(bromomethyl)-biphenyl-2-yl>tetrazole (124750-51-2)

Conditions	Yield
Multi-step reaction with 3 steps 1: 1.) Mg, I2; n-Bu3SnCl, 2.) Pd(PPh3)2Cl2, LiCl / 1.) THF, reflux, 30 min; THF, reflux, 20 h, 2.) DMF, 98 deg C, 24 h 2: 1.) NaN3, n-Bu3SnCl, 2.) NaOH / 1.) toluene, 115 deg C, 70 h, 2.) toluene, r.t., 3 h 3: NBS, AIBN / CCl4 / 3 h / Heating View Scheme

o-cyanobromobenzene (2042-37-7) → N-(triephenylmethyl)-5-<4'-(bromomethyl)-biphenyl-2-yl>tetrazole (124750-51-2)

Conditions	Yield
Multi-step reaction with 3 steps 1: 1.) Mg, I2; n-Bu3SnCl, 2.) Pd(PPh3)2Cl2, LiCl / 1.) THF, reflux, 30 min; THF, reflux, 20 h, 2.) DMF, 98 deg C, 24 h 2: 1.) NaN3, n-Bu3SnCl, 2.) NaOH / 1.) toluene, 115 deg C, 70 h, 2.) toluene, r.t., 3 h 3: NBS, AIBN / CCl4 / 3 h / Heating View Scheme
Multi-step reaction with 3 steps 1: bis-triphenylphosphine-palladium(II) chloride; lithium chloride / N,N-dimethyl-formamide / Inert atmosphere 2: sodium azide; tributyltin chloride / toluene / Reflux 3: N-Bromosuccinimide; dibenzoyl peroxide / tetrachloromethane View Scheme
Multi-step reaction with 4 steps 1.1: palladium dichloride / methanol; toluene / 0.17 h / 20 °C / Inert atmosphere 1.2: 12 h / 110 °C / Inert atmosphere 2.1: zinc(II) chloride; sodium azide / N,N-dimethyl-formamide / 48 h / 120 °C 3.1: triethylamine / dichloromethane / 2 h / 0 °C / Reflux 4.1: dibenzoyl peroxide; N-Bromosuccinimide / tetrachloromethane / 3 h / Reflux View Scheme

2-Cyano-4'-methylbiphenyl (114772-53-1) → N-(triephenylmethyl)-5-<4'-(bromomethyl)-biphenyl-2-yl>tetrazole (124750-51-2)

Conditions	Yield
Multi-step reaction with 2 steps 1: 1.) NaN3, n-Bu3SnCl, 2.) NaOH / 1.) toluene, 115 deg C, 70 h, 2.) toluene, r.t., 3 h 2: NBS, AIBN / CCl4 / 3 h / Heating View Scheme
Multi-step reaction with 3 steps 1: sodium azide; triethylamine hydrochloride / toluene / 18 h / 105 - 110 °C 2: toluene / 3 h / 20 °C 3: N-Bromosuccinimide; dihydrogen peroxide / dichloromethane / Reflux View Scheme
Multi-step reaction with 2 steps 1: sodium azide; tributyltin chloride / toluene / Reflux 2: N-Bromosuccinimide; dibenzoyl peroxide / tetrachloromethane View Scheme

trityl chloride (76-83-5) + DL-lysine methyl ester dihydrochloride → N-(triephenylmethyl)-5-<4'-(bromomethyl)-biphenyl-2-yl>tetrazole (124750-51-2)

Conditions	Yield
Multi-step reaction with 2 steps 1: 1.) NaN3, n-Bu3SnCl, 2.) NaOH / 1.) toluene, 115 deg C, 70 h, 2.) toluene, r.t., 3 h 2: NBS, AIBN / CCl4 / 3 h / Heating View Scheme

2-<(trifluoromethanesulfonyl)oxy>benzonitrile (138313-23-2) → N-(triephenylmethyl)-5-<4'-(bromomethyl)-biphenyl-2-yl>tetrazole (124750-51-2)

Conditions	Yield
Multi-step reaction with 3 steps 1: 1.) Mg, I2; n-Bu3SnCl, 2.) Pd(PPh3)2Cl2, LiCl / 1.) THF, reflux, 30 min; THF, reflux, 20 h, 2.) DMF, 98 deg C, 24 h 2: 1.) NaN3, n-Bu3SnCl, 2.) NaOH / 1.) toluene, 115 deg C, 70 h, 2.) toluene, r.t., 3 h 3: NBS, AIBN / CCl4 / 3 h / Heating View Scheme

2-(tetrazol-5-yl)-4'-methyl-1,1'-biphenyl (120568-11-8) → N-(triephenylmethyl)-5-<4'-(bromomethyl)-biphenyl-2-yl>tetrazole (124750-51-2)

Conditions	Yield
Multi-step reaction with 2 steps 1: toluene / 3 h / 20 °C 2: N-Bromosuccinimide; dihydrogen peroxide / dichloromethane / Reflux View Scheme
Multi-step reaction with 2 steps 1: triethylamine / dichloromethane / 2 h / 0 °C / Reflux 2: dibenzoyl peroxide; N-Bromosuccinimide / tetrachloromethane / 3 h / Reflux View Scheme
Multi-step reaction with 2 steps 1: potassium hydroxide / methanol 2: bromine; acetic acid View Scheme

tributyl(p-tolyl)stannane (31614-66-1) → N-(triephenylmethyl)-5-<4'-(bromomethyl)-biphenyl-2-yl>tetrazole (124750-51-2)

Conditions	Yield
Multi-step reaction with 3 steps 1: bis-triphenylphosphine-palladium(II) chloride; lithium chloride / N,N-dimethyl-formamide / Inert atmosphere 2: sodium azide; tributyltin chloride / toluene / Reflux 3: N-Bromosuccinimide; dibenzoyl peroxide / tetrachloromethane View Scheme

4-methylphenylboronic acid (5720-05-8) → N-(triephenylmethyl)-5-<4'-(bromomethyl)-biphenyl-2-yl>tetrazole (124750-51-2)

Conditions	Yield
Multi-step reaction with 4 steps 1.1: palladium dichloride / methanol; toluene / 0.17 h / 20 °C / Inert atmosphere 1.2: 12 h / 110 °C / Inert atmosphere 2.1: zinc(II) chloride; sodium azide / N,N-dimethyl-formamide / 48 h / 120 °C 3.1: triethylamine / dichloromethane / 2 h / 0 °C / Reflux 4.1: dibenzoyl peroxide; N-Bromosuccinimide / tetrachloromethane / 3 h / Reflux View Scheme
Multi-step reaction with 4 steps 1: palladium diacetate; triethylamine; triphenylphosphine / acetonitrile 2: sodium azide / N,N-dimethyl-formamide 3: potassium hydroxide / methanol 4: bromine; acetic acid View Scheme
Multi-step reaction with 4 steps 1: palladium diacetate; triphenylphosphine / acetonitrile 2: sodium azide / N,N-dimethyl-formamide 3: potassium hydroxide / methanol 4: bromine; acetic acid View Scheme

o-tolylbenzoic acid (7148-03-0) → N-(triephenylmethyl)-5-<4'-(bromomethyl)-biphenyl-2-yl>tetrazole (124750-51-2)

Conditions	Yield
Multi-step reaction with 6 steps 1: thionyl chloride 2: sodium hydroxide 3: trimethylsilylazide; diethylazodicarboxylate; triphenylphosphine 4: sodium hydroxide / tetrahydrofuran; methanol 5: N-ethyl-N,N-diisopropylamine 6: N-Bromosuccinimide / tetrachloromethane View Scheme

4'-methylbiphenyl-2-carboxylic acid chloride (114772-35-9) → N-(triephenylmethyl)-5-<4'-(bromomethyl)-biphenyl-2-yl>tetrazole (124750-51-2)

Conditions	Yield
Multi-step reaction with 5 steps 1: sodium hydroxide 2: trimethylsilylazide; diethylazodicarboxylate; triphenylphosphine 3: sodium hydroxide / tetrahydrofuran; methanol 4: N-ethyl-N,N-diisopropylamine 5: N-Bromosuccinimide / tetrachloromethane View Scheme

N-(2-cyanoethyl)-4'-methyl[1,1']biphenyl-2-carboxamide (120568-15-2) → N-(triephenylmethyl)-5-<4'-(bromomethyl)-biphenyl-2-yl>tetrazole (124750-51-2)

Conditions	Yield
Multi-step reaction with 4 steps 1: trimethylsilylazide; diethylazodicarboxylate; triphenylphosphine 2: sodium hydroxide / tetrahydrofuran; methanol 3: N-ethyl-N,N-diisopropylamine 4: N-Bromosuccinimide / tetrachloromethane View Scheme

5-<4'-Methyl-1,1'-biphenyl-2-yl>-1H-tetrazole-1-propanenitrile (120568-17-4) → N-(triephenylmethyl)-5-<4'-(bromomethyl)-biphenyl-2-yl>tetrazole (124750-51-2)

Conditions	Yield
Multi-step reaction with 3 steps 1: sodium hydroxide / tetrahydrofuran; methanol 2: N-ethyl-N,N-diisopropylamine 3: N-Bromosuccinimide / tetrachloromethane View Scheme

C17H20N4Si → N-(triephenylmethyl)-5-<4'-(bromomethyl)-biphenyl-2-yl>tetrazole (124750-51-2)

Conditions	Yield
Multi-step reaction with 2 steps 2: N-Bromosuccinimide / tetrachloromethane View Scheme

C26H22Zn → N-(triephenylmethyl)-5-<4'-(bromomethyl)-biphenyl-2-yl>tetrazole (124750-51-2)

Conditions	Yield
Multi-step reaction with 4 steps 1: nickel 2: toluene 4: N-Bromosuccinimide / tetrachloromethane View Scheme

para-bromotoluene (106-38-7) → N-(triephenylmethyl)-5-<4'-(bromomethyl)-biphenyl-2-yl>tetrazole (124750-51-2)

Conditions	Yield
Multi-step reaction with 6 steps 1: magnesium / tetrahydrofuran / 2 h / 20 °C 2: tetrahydrofuran / 3 h / 20 °C 3: pyridine; trichlorophosphate / 3 h / 10 - 100 °C 4: toluene 6: N-Bromosuccinimide / tetrachloromethane View Scheme
Multi-step reaction with 9 steps 1: magnesium / tetrahydrofuran / 2 h / 20 °C 2: tetrahydrofuran / 3 h / 20 °C 3: hydrogenchloride / water 4: thionyl chloride 5: sodium hydroxide 6: trimethylsilylazide; diethylazodicarboxylate; triphenylphosphine 7: sodium hydroxide / tetrahydrofuran; methanol 8: N-ethyl-N,N-diisopropylamine 9: N-Bromosuccinimide / tetrachloromethane View Scheme

para-methylphenylmagnesium bromide (4294-57-9) → N-(triephenylmethyl)-5-<4'-(bromomethyl)-biphenyl-2-yl>tetrazole (124750-51-2)

Conditions	Yield
Multi-step reaction with 5 steps 1: tetrahydrofuran / 3 h / 20 °C 2: pyridine; trichlorophosphate / 3 h / 10 - 100 °C 3: toluene 5: N-Bromosuccinimide / tetrachloromethane View Scheme
Multi-step reaction with 8 steps 1: tetrahydrofuran / 3 h / 20 °C 2: hydrogenchloride / water 3: thionyl chloride 4: sodium hydroxide 5: trimethylsilylazide; diethylazodicarboxylate; triphenylphosphine 6: sodium hydroxide / tetrahydrofuran; methanol 7: N-ethyl-N,N-diisopropylamine 8: N-Bromosuccinimide / tetrachloromethane View Scheme

4,4-dimethyl-2-(4'-methyl-biphenyl-2-yl)-4,5-dihydrooxazole (84392-32-5) → N-(triephenylmethyl)-5-<4'-(bromomethyl)-biphenyl-2-yl>tetrazole (124750-51-2)

Conditions	Yield
Multi-step reaction with 4 steps 1: pyridine; trichlorophosphate / 3 h / 10 - 100 °C 2: toluene 4: N-Bromosuccinimide / tetrachloromethane View Scheme
Multi-step reaction with 7 steps 1: hydrogenchloride / water 2: thionyl chloride 3: sodium hydroxide 4: trimethylsilylazide; diethylazodicarboxylate; triphenylphosphine 5: sodium hydroxide / tetrahydrofuran; methanol 6: N-ethyl-N,N-diisopropylamine 7: N-Bromosuccinimide / tetrachloromethane View Scheme

4'-(hydroxymethyl)-[1,1'-biphenyl]-2-carbonitrile (154709-19-0) → N-(triephenylmethyl)-5-<4'-(bromomethyl)-biphenyl-2-yl>tetrazole (124750-51-2)

Conditions	Yield
Multi-step reaction with 3 steps 1.1: zinc(II) chloride; sodium azide / butan-1-ol / 20 h / 100 - 105 °C 2.1: triethylamine / dichloromethane / 10 - 15 °C 2.2: 10 °C / Reflux 3.1: potassium bromide; sulfuric acid / N,N-dimethyl acetamide / 7 h / 10 - 25 °C View Scheme

biphenyl-2-carbonitrile (24973-49-7) → N-(triephenylmethyl)-5-<4'-(bromomethyl)-biphenyl-2-yl>tetrazole (124750-51-2)

Conditions	Yield
Multi-step reaction with 4 steps 1.1: zinc(II) chloride; hydrogenchloride / 1,2-dimethoxyethane; water / 0 - 5 °C 2.1: zinc(II) chloride; sodium azide / butan-1-ol / 20 h / 100 - 105 °C 3.1: triethylamine / dichloromethane / 10 - 15 °C 3.2: 10 °C / Reflux 4.1: potassium bromide; sulfuric acid / N,N-dimethyl acetamide / 7 h / 10 - 25 °C View Scheme

C35H28N4O2 → N-(triephenylmethyl)-5-<4'-(bromomethyl)-biphenyl-2-yl>tetrazole (124750-51-2)

Conditions	Yield
Multi-step reaction with 3 steps 1.1: hydrogenchloride / tetrahydrofuran; water / 3 h / 20 °C 2.1: sodium tetrahydroborate / methanol / 1 h / 5 - 20 °C 2.2: 0.25 h / 0 °C 3.1: phosphorus tribromide / dichloromethane / 1 h / 10 - 20 °C View Scheme

5-<2-(4'-formylbiphenylyl)>-2-(triphenylmethyl)-2H-tetrazole (155983-56-5) → N-(triephenylmethyl)-5-<4'-(bromomethyl)-biphenyl-2-yl>tetrazole (124750-51-2)

Conditions	Yield
Multi-step reaction with 2 steps 1.1: sodium tetrahydroborate / methanol / 1 h / 5 - 20 °C 1.2: 0.25 h / 0 °C 2.1: phosphorus tribromide / dichloromethane / 1 h / 10 - 20 °C View Scheme

2-(4-chlorophenyl)-1,3-dioxolane (2403-54-5) → N-(triephenylmethyl)-5-<4'-(bromomethyl)-biphenyl-2-yl>tetrazole (124750-51-2)

Conditions

Yield

Multi-step reaction with 5 steps 1.1: magnesium; iodine / tetrahydrofuran; toluene / 5 h / Inert atmosphere; Reflux 2.1: tributyltin chloride; sodium azide / toluene; N,N-dimethyl-formamide / 48 h / Reflux 3.1: hydrogenchloride / tetrahydrofuran; water / 3 h / 20 °C 4.1: sodium tetrahydroborate / methanol / 1 h / 5 - 20 °C 4.2: 0.25 h / 0 °C 5.1: phosphorus tribromide / dichloromethane / 1 h / 10 - 20 °C View Scheme

2-Chlorobenzonitrile (873-32-5) → N-(triephenylmethyl)-5-<4'-(bromomethyl)-biphenyl-2-yl>tetrazole (124750-51-2)

Conditions

Yield

Multi-step reaction with 5 steps 1.1: magnesium; iodine / tetrahydrofuran; toluene / 5 h / Inert atmosphere; Reflux 2.1: tributyltin chloride; sodium azide / toluene; N,N-dimethyl-formamide / 48 h / Reflux 3.1: hydrogenchloride / tetrahydrofuran; water / 3 h / 20 °C 4.1: sodium tetrahydroborate / methanol / 1 h / 5 - 20 °C 4.2: 0.25 h / 0 °C 5.1: phosphorus tribromide / dichloromethane / 1 h / 10 - 20 °C View Scheme

2-propyl-4,5-bis(methoxycarbonyl)-imidazole (124750-59-0) + N-(triephenylmethyl)-5-<4'-(bromomethyl)-biphenyl-2-yl>tetrazole (124750-51-2) → 2-propyl-1-[2'-(1-triphenylmethyl-1H-tetrazol-5-yl)biphenyl-4-ylmethyl]-1H-imidazole-4,5-dicarboxylic acid dimethyl ester (124750-61-4)

Conditions	Yield
With potassium carbonate In N,N-dimethyl acetamide; acetone Reflux; Large scale reaction;	99%

N-(triephenylmethyl)-5-<4'-(bromomethyl)-biphenyl-2-yl>tetrazole (124750-51-2) → [2'-(N-Triphenylmethyl-tetrazol-5-yl)-biphenyl-4-yl]methyl azide (124806-66-2)

Conditions	Yield
In N-methyl-acetamide	96%
With sodium azide In N,N-dimethyl-formamide at 70℃; for 0.333333h;	96%
In dimethyl sulfoxide
With sodium azide In water; N,N-dimethyl-formamide at 20℃; for 22h;

[2'-(N-Triphenylmethyl-tetrazol-5-yl)-biphenyl-4-yl]methyl azide (124806-66-2) + 5-butyl-2,4-dihydro-4-[[2-(1-triphenylmethyl-1H-tetrazol-5-yl)-[1,1'-biphenyl]-4'-yl]methyl]-3H-1,2,4-triazol-3-one (169598-69-0) + dichloromethane (75-09-2) + N-(triephenylmethyl)-5-<4'-(bromomethyl)-biphenyl-2-yl>tetrazole (124750-51-2) → 2,4-Bis[[2'-(N-trityltetrazol-5-yl)biphenyl-4-yl]methyl]-5-n-butyl-2,4-dihydro-3H-1,2,4-triazol-3-one

Conditions	Yield
In methanol	96%

L-valine benzyl ester hydrochloride (2462-34-2) + N-(triephenylmethyl)-5-<4'-(bromomethyl)-biphenyl-2-yl>tetrazole (124750-51-2) → N-[(2'-(1-triphenylmethyl-tetrazol-5-yl)biphenyl-4-yl)methyl]-(L)-valine benzyl ester phosphite

Conditions	Yield
Stage #1: L-valine benzyl ester hydrochloride With sodium hydroxide In water; ethyl acetate for 0.333333h; pH=10 - 12; Stage #2: N-(triephenylmethyl)-5-<4'-(bromomethyl)-biphenyl-2-yl>tetrazole In ethyl acetate at 55 - 60℃; Stage #3: With phosphonic Acid In ethyl acetate for 1h;	95%

L-valine benzyl ester hydrochloride (2462-34-2) + N-(triephenylmethyl)-5-<4'-(bromomethyl)-biphenyl-2-yl>tetrazole (124750-51-2) → N-[(2'-(1-triphenylmethyltetrazol-5-yl)biphenyl-4-yl)methyl]-(L)-valine benzyl ester phosphorous acid salt

Conditions	Yield
Stage #1: L-valine benzyl ester hydrochloride With sodium hydroxide In water pH=10 - 12; Stage #2: N-(triephenylmethyl)-5-<4'-(bromomethyl)-biphenyl-2-yl>tetrazole In ethyl acetate at 55 - 60℃; Stage #3: With phosphorous acid In ethyl acetate for 1h;	95%

2-(2-n-butyl-4-hydroxy-6-methylpyrimidin-5-yl)-N,N-dimethylthioacetamide + N-(triephenylmethyl)-5-<4'-(bromomethyl)-biphenyl-2-yl>tetrazole (124750-51-2) → 2-n-butyl-5-(N,N-dimethylaminothioformylmethyl)-6-methyl-3-[[2'-(N-triphenylmethyl-5-tetrazolyl)biphenyl]-4-methyl]pyrimidin-4-one (1361024-52-3)

Conditions	Yield
Stage #1: 2-(2-n-butyl-4-hydroxy-6-methylpyrimidin-5-yl)-N,N-dimethylthioacetamide With lithium hydride In hexane; N,N-dimethyl-formamide at 0℃; for 1h; Inert atmosphere; Stage #2: N-(triephenylmethyl)-5-<4'-(bromomethyl)-biphenyl-2-yl>tetrazole In hexane; N,N-dimethyl-formamide at 70℃; for 24h; Inert atmosphere;	95%

N-(triephenylmethyl)-5-<4'-(bromomethyl)-biphenyl-2-yl>tetrazole (124750-51-2) + 2-butyl-1,3-diazaspiro[4.4]non-1-en-4-one hydrochloride → 2-n-butyl-4-spirocyclopentane-1-[(2'-(tetrazol-5-yl)biphenyl-4-yl)methyl]-2-imidazolin-5-one hydrochloride sesquihydrate

Conditions	Yield
Stage #1: N-(triephenylmethyl)-5-<4'-(bromomethyl)-biphenyl-2-yl>tetrazole; 2-butyl-1,3-diazaspiro[4.4]non-1-en-4-one hydrochloride With potassium hydroxide; tetrabutylammomium bromide In water; toluene at 85℃; for 2h; Stage #2: With hydrogenchloride; water In toluene at 55℃; for 0.75h; Product distribution / selectivity;	94%
Stage #1: N-(triephenylmethyl)-5-<4'-(bromomethyl)-biphenyl-2-yl>tetrazole; 2-butyl-1,3-diazaspiro[4.4]non-1-en-4-one hydrochloride With potassium hydroxide; tetrabutylammomium bromide In xylene at 85℃; for 2h; Stage #2: With hydrogenchloride; water In xylene at 55℃; for 0.75h; Product distribution / selectivity;	94%
Stage #1: N-(triephenylmethyl)-5-<4'-(bromomethyl)-biphenyl-2-yl>tetrazole; 2-butyl-1,3-diazaspiro[4.4]non-1-en-4-one hydrochloride With sodium hydroxide; 18-crown-6 ether In xylene at 85℃; for 2 - 4h; Stage #2: With hydrogenchloride; water In xylene at 55℃; for 0.75h; Product distribution / selectivity;	94%

N-(triephenylmethyl)-5-<4'-(bromomethyl)-biphenyl-2-yl>tetrazole (124750-51-2) + ethyl 4-(2-hydroxypropan-2-yl)-2-propyl-1H-imidazole-5-carboxylate (144689-93-0) → ethyl 4-(2-hydroxypropan-2-yl)-2-propyl-1-({2'-[1-(triphenylmethyl)-1H-1,2,3,4-tetrazol-5-yl]-[1,1'-biphenyl]-4-yl}methyl)-1H-imidazole-5-carboxylate (144690-33-5)

Conditions	Yield
Stage #1: N-(triephenylmethyl)-5-<4'-(bromomethyl)-biphenyl-2-yl>tetrazole; ethyl 4-(2-hydroxypropan-2-yl)-2-propyl-1H-imidazole-5-carboxylate With potassium carbonate In butanone at 60℃; for 2h; Stage #2: With N,N-dimethyl acetamide In butanone at 45℃; for 4h;	93.8%
With tetrabutylammomium bromide; potassium carbonate In acetone at 50 - 60℃; for 20h; Green chemistry;	90.7%
With potassium carbonate In acetonitrile for 7h; Heating / reflux;	89%

N-(triephenylmethyl)-5-<4'-(bromomethyl)-biphenyl-2-yl>tetrazole (124750-51-2) + 2-butyl-1,3-diazaspiro[4.4]non-1-en-4-one hydrochloride → 2-butyl-3-{4-[2-(1H-tetrazol-5-yl)phenyl]benzyl}-1,3-diazaspiro[4.4]non-1-en-4-one (138402-11-6)

Conditions	Yield
Stage #1: N-(triephenylmethyl)-5-<4'-(bromomethyl)-biphenyl-2-yl>tetrazole; 2-butyl-1,3-diazaspiro[4.4]non-1-en-4-one hydrochloride With sodium hydroxide; tetrabutylammomium bromide In water; toluene at 85℃; for 2h; Stage #2: With hydrogenchloride; water In acetone at 20℃; Stage #3: With potassium hydroxide In water; acetone Product distribution / selectivity;	92%
With potassium hydroxide; tetra(n-butyl)ammonium hydrogensulfate In water; toluene at 90℃; for 1.5h; Heating / reflux;	84.3%
Stage #1: N-(triephenylmethyl)-5-<4'-(bromomethyl)-biphenyl-2-yl>tetrazole; 2-butyl-1,3-diazaspiro[4.4]non-1-en-4-one hydrochloride With potassium hydroxide; tetra(n-butyl)ammonium hydrogensulfate In water; toluene at 90℃; for 1.5h; Stage #2: With hydrogenchloride; water In acetone at 20℃; Stage #3: With potassium hydroxide In water; acetone Product distribution / selectivity;	84%
Stage #1: N-(triephenylmethyl)-5-<4'-(bromomethyl)-biphenyl-2-yl>tetrazole; 2-butyl-1,3-diazaspiro[4.4]non-1-en-4-one hydrochloride With tetrabutylammomium bromide; potassium carbonate In ethyl acetate at 25 - 80℃; for 10h; Stage #2: With hydrogenchloride In methanol at 0 - 30℃; for 3.5h; Stage #3: With sodium hydroxide In water; toluene at 0 - 30℃; for 0.5h; pH=12;

N-(triephenylmethyl)-5-<4'-(bromomethyl)-biphenyl-2-yl>tetrazole (124750-51-2) + 2-butyl-1,3-diazaspiro[4.4]non-1-en-4-one hydrochloride → 2-n-butyl-4-spirocyclopentane-1-[(2'-(tetrazol-5-yl)biphenyl-4-yl)methyl]-2-imidazolin-5-one hydrochloride hemihydrate

Conditions	Yield
Stage #1: N-(triephenylmethyl)-5-<4'-(bromomethyl)-biphenyl-2-yl>tetrazole; 2-butyl-1,3-diazaspiro[4.4]non-1-en-4-one hydrochloride With sodium hydroxide; tetrabutylammomium bromide In water; toluene at 85℃; for 2h; Stage #2: With hydrogenchloride; water In toluene at 55℃; for 0.75h; Product distribution / selectivity;	92%
Stage #1: N-(triephenylmethyl)-5-<4'-(bromomethyl)-biphenyl-2-yl>tetrazole; 2-butyl-1,3-diazaspiro[4.4]non-1-en-4-one hydrochloride With potassium hydroxide In toluene at 85℃; for 2h; Stage #2: With hydrogenchloride; water In toluene at 55℃; for 0.75h; Product distribution / selectivity;	69%
Stage #1: N-(triephenylmethyl)-5-<4'-(bromomethyl)-biphenyl-2-yl>tetrazole; 2-butyl-1,3-diazaspiro[4.4]non-1-en-4-one hydrochloride With potassium carbonate In MIBK (methyl isobutyl ketone); water at 85℃; for 2h; Stage #2: With hydrogenchloride; water In MIBK (methyl isobutyl ketone) at 55℃; for 0.75h; Product distribution / selectivity;	69%

ethyl 2-[(N-tert-butoxycarbonyl)amino]-3-nitrobenzoate (136285-65-9) + N-(triephenylmethyl)-5-<4'-(bromomethyl)-biphenyl-2-yl>tetrazole (124750-51-2) → ethyl 2-[(N-tert-butoxycarbonyl)-[[2'-[1-(triphenylmethyl)-1H-tetrazol-5-yl]biphenyl-4-yl]methyl]amino]-3-nitrobenzoate (906474-56-4)

Conditions	Yield
With potassium carbonate In acetonitrile for 5h; Reflux;	92%
With potassium carbonate In acetonitrile at 80℃; for 7h;

4-methoxy-aniline (104-94-9) + N-(triephenylmethyl)-5-<4'-(bromomethyl)-biphenyl-2-yl>tetrazole (124750-51-2) → 4-methoxy-N-((2'-(1-trityl-1H-tetrazol-5-yl)biphenyl-4-yl)methyl)aniline

Conditions	Yield
With potassium carbonate In N,N-dimethyl-formamide Reflux;	92%

2-(2-thienyl)-1,3-diazaspiro[4.4]non-1-en-4-one (1199814-93-1) + N-(triephenylmethyl)-5-<4'-(bromomethyl)-biphenyl-2-yl>tetrazole (124750-51-2) → 2-(2-thienyl)-3-[2'-(1-trityl-1H-tetrazol-5-yl)-biphenyl-4-ylmethyl]-1,3-diazaspiro[4.4]non-1-en-4-one (1199814-94-2)

Conditions	Yield
Stage #1: 2-(2-thienyl)-1,3-diazaspiro[4.4]non-1-en-4-one With sodium hydride In N,N-dimethyl-formamide at 20℃; for 0.25h; Stage #2: N-(triephenylmethyl)-5-<4'-(bromomethyl)-biphenyl-2-yl>tetrazole In N,N-dimethyl-formamide at 20℃;	91%

N-(3-methoxy)benzyl-4-methyl-2-n-propyl-1H-benzimidazole-6-carboxamide (1239196-62-3) + N-(triephenylmethyl)-5-<4'-(bromomethyl)-biphenyl-2-yl>tetrazole (124750-51-2) → N-(3-methoxy)benzyl-1-([2'-(1-triphenylmethyltetrazol-5-yl)-(1,1'-biphenyl)-4-yl]methyl)-4-methyl-2-n-propyl-1H-benzimidazole-6-carboxamide (1390645-40-5)

Conditions	Yield
Stage #1: N-(3-methoxy)benzyl-4-methyl-2-n-propyl-1H-benzimidazole-6-carboxamide With potassium tert-butylate In N,N-dimethyl-formamide at 0℃; for 0.5h; Stage #2: N-(triephenylmethyl)-5-<4'-(bromomethyl)-biphenyl-2-yl>tetrazole In N,N-dimethyl-formamide at 0 - 25℃; for 12h;	90.2%

2,2,2-trifluoroacetamide (354-38-1) + N-(triephenylmethyl)-5-<4'-(bromomethyl)-biphenyl-2-yl>tetrazole (124750-51-2) → C35H26F3N5O (868742-05-6)

Conditions	Yield
With 18-crown-6 ether; potassium tert-butylate In tetrahydrofuran; diethyl ether at 20℃; for 96h;	90%

N-(triephenylmethyl)-5-<4'-(bromomethyl)-biphenyl-2-yl>tetrazole (124750-51-2) + 2-butyl-1,3-diazaspiro[4.4]non-1-en-4-one hydrochloride → trityl irbesartan (138402-10-5)

Conditions	Yield
In N,N-dimethyl-formamide for 0.0194444h; microwave irradiation;	90%

trityl chloride (76-83-5) + N-(triephenylmethyl)-5-<4'-(bromomethyl)-biphenyl-2-yl>tetrazole (124750-51-2) + (S)-4-isopropyl-2-(thiophen-2-yl)-4,5-dihydrooxazole (149065-76-9) → (1S)-N-(1-hydroxymethyl-2-methyl-propyl)-N'-[2'-(1-trityl-1H-tetrazol-5-yl)-biphenyl-4-ylmethyl]-thiophene-2-carboxamide (1033772-55-2)

Conditions	Yield
With potassium carbonate; potassium iodide In butanone for 24h; Product distribution / selectivity; Heating / reflux;	90%

N-(triephenylmethyl)-5-<4'-(bromomethyl)-biphenyl-2-yl>tetrazole (124750-51-2) + 2-amino-phenol (95-55-6) → 2-hydroxy-N-((2'-(1-trityl-1H-tetrazol-5-yl)biphenyl-4-yl)methyl)aniline

Conditions	Yield
With potassium carbonate In N,N-dimethyl-formamide Reflux;	90%

N-(triephenylmethyl)-5-<4'-(bromomethyl)-biphenyl-2-yl>tetrazole (124750-51-2) + 3-fluoro-4-(morpholinyl)aniline (93246-53-8) → 3-fluoro-4-morpholino-N-((2'-(1-trityl-1H-tetrazol-5-yl)-biphenyl-4-yl)methyl)aniline

Conditions	Yield
With potassium carbonate In N,N-dimethyl-formamide Reflux;	90%

N-benzyl-4-methyl-2-n-propyl-1H-benzimidazole-6-carboxamide (1239196-56-5) + N-(triephenylmethyl)-5-<4'-(bromomethyl)-biphenyl-2-yl>tetrazole (124750-51-2) → N-benzyl-1-([2'-(1-triphenylmethyltetrazol-5-yl)-(1,1'-biphenyl)-4-yl]methyl)-4-methyl-2-n-propyl-1H-benzimidazole-6-carboxamide (1390645-39-2)

Conditions	Yield
Stage #1: N-benzyl-4-methyl-2-n-propyl-1H-benzimidazole-6-carboxamide With potassium tert-butylate In N,N-dimethyl-formamide at 0℃; for 0.5h; Stage #2: N-(triephenylmethyl)-5-<4'-(bromomethyl)-biphenyl-2-yl>tetrazole In N,N-dimethyl-formamide at 0 - 25℃; for 12h;	89.7%

N-(triephenylmethyl)-5-<4'-(bromomethyl)-biphenyl-2-yl>tetrazole (124750-51-2) + ethyl 4-(2-hydroxypropan-2-yl)-2-propyl-1H-imidazole-5-carboxylate (144689-93-0) → ethyl 4-(2-hydroxypropan-2-yl)-2-propyl-1-({2'-[1-(triphenylmethyl)-1H-1,2,3,4-tetrazol-5-yl]-[1,1'-biphenyl]-4-yl}methyl)-1H-imidazole-5-carboxylate (144690-33-5) + 4-(1-hydroxy-1-methylethyl)-2-propyl-1-(4-(2-(1-(triphenylmethyl)tetrazol-5-yl)phenyl)phenyl)methylimidazole-5-carboxylic acid (761404-85-7) + C45H42N6O2

Conditions	Yield
With potassium phosphate In N,N-dimethyl acetamide at 60 - 65℃; for 6h; Solvent; Reagent/catalyst;	A 89.6% B 0.02% C 0.02%

p-toluidine (106-49-0) + N-(triephenylmethyl)-5-<4'-(bromomethyl)-biphenyl-2-yl>tetrazole (124750-51-2) → 4-methyl-N-((2'-(1-trityl-1H-tetrazol-5-yl)biphenyl-4-yl)methyl)aniline

Conditions	Yield
With potassium carbonate In N,N-dimethyl-formamide Reflux;	89%

N-(triephenylmethyl)-5-<4'-(bromomethyl)-biphenyl-2-yl>tetrazole (124750-51-2) + (4-acetyl-5-methyl-1-pentanoylamino-1H-pyrrol-2-yl)-acetic acid ethyl ester (230627-21-1) → (4-acetyl-5-methyl-1-{pentanoyl-[2'-(1-trityl-1H-tetrazol-5-yl)-biphenyl-4-ylmethyl]-amino}-1H-pyrrol-2-yl)-acetic acid ethyl ester (230627-26-6)

Conditions	Yield
With sodium hydroxide In dichloromethane at 20℃; Alkylation;	88.7%

1H-Naphtho<2,3-d><1,2,3>triazole (269-12-5) + N-(triephenylmethyl)-5-<4'-(bromomethyl)-biphenyl-2-yl>tetrazole (124750-51-2) → 1-[2'-(1-triphenylmethyl-1H-tetrazol-5-yl)-biphenyl-4-ylmethyl]-1H-naphtho[2,3-d][1,2,3]triazole (194417-18-0)

Conditions	Yield
With sodium hydride In N,N-dimethyl-formamide at 0℃; 1.) 1h, 2.) 0 deg C, 4 h; r.t., overnight;	88%

4-amino-benzoic acid (150-13-0) + N-(triephenylmethyl)-5-<4'-(bromomethyl)-biphenyl-2-yl>tetrazole (124750-51-2) → 4-carboxy-N-((2'-(1-trityl-1H-tetrazol-5-yl)biphenyl-4-yl)methyl)aniline

Conditions	Yield
With potassium carbonate In N,N-dimethyl-formamide Reflux;	88%

N-(triephenylmethyl)-5-<4'-(bromomethyl)-biphenyl-2-yl>tetrazole (124750-51-2) + N-butylamine (109-73-9) → 1-trityl-5-(4'-butylaminomethyl-1,1'-biphenyl-2-yl)-1H-tetrazole

Conditions	Yield
In tetrahydrofuran at 20℃; for 3h;	88%
In tetrahydrofuran at 20℃; for 2h;	80%

N-(triephenylmethyl)-5-<4'-(bromomethyl)-biphenyl-2-yl>tetrazole (124750-51-2) → 5-(4'-(chloromethyl)-[1,1'-biphenyl]-2-yl)-1H-tetrazole

Conditions	Yield
With hydrogenchloride In water; ethyl acetate at 80℃; for 15h; Temperature; Solvent;	88%

N-(4-methoxy)benzyl-4-methyl-2-n-propyl-1H-benzimidazole-6-carboxamide (1239196-65-6) + N-(triephenylmethyl)-5-<4'-(bromomethyl)-biphenyl-2-yl>tetrazole (124750-51-2) → N-(4-methoxy)benzyl-1-([2'-(1-triphenylmethyltetrazol-5-yl)-(1,1'-biphenyl)-4-yl]methyl)-4-methyl-2-n-propyl-1H-benzimidazole-6-carboxamide (1390645-41-6)

Conditions	Yield
Stage #1: N-(4-methoxy)benzyl-4-methyl-2-n-propyl-1H-benzimidazole-6-carboxamide With potassium tert-butylate In N,N-dimethyl-formamide at 0℃; for 0.5h; Stage #2: N-(triephenylmethyl)-5-<4'-(bromomethyl)-biphenyl-2-yl>tetrazole In N,N-dimethyl-formamide at 0 - 25℃; for 12h;	87.7%

Upstream product

• 124750-53-4 N-triphenylmethyl-5-(4'-methylbiphenyl-2-yl)tetrazole 
• 611-20-1 salicylonitrile 
• 624-31-7 4-tolyl iodide 
• 2042-37-7 o-cyanobromobenzene 
• 114772-53-1 2-Cyano-4'-methylbiphenyl 
• 138313-23-2 2-<(trifluoromethanesulfonyl)oxy>benzonitrile 
• 120568-11-8 2-(tetrazol-5-yl)-4'-methyl-1,1'-biphenyl 
• 31614-66-1 tributyl(p-tolyl)stannane 
• 7148-03-0 o-tolylbenzoic acid 
• 114772-35-9 4'-methylbiphenyl-2-carboxylic acid chloride 
• 120568-15-2 N-(2-cyanoethyl)-4'-methyl[1,1']biphenyl-2-carboxamide 
• 120568-17-4 5-<4'-Methyl-1,1'-biphenyl-2-yl>-1H-tetrazole-1-propanenitrile 
• 106-38-7 para-bromotoluene 
• 4294-57-9 para-methylphenylmagnesium bromide 

Downstream Products

• 154709-17-8 5-<2-<4'-(acetoxymethyl)biphenylyl>>-2-(triphenylmethyl)-2H-tetrazole 
• 135015-78-0 2-Ethyl-7-methoxy-4-[(2'-(1H-tetrazol-5-yl)biphenyl-4-yl)methoxy]quinoline hydrochloride 
• 145319-00-2 2-Butyl-6-chloro-4,4-dimethyl-1-[2'-(1-trityl-1H-tetrazol-5-yl)-biphenyl-4-ylmethyl]-1,4-dihydro-pyrimidine-5-carboxylic acid ethyl ester 
• 145319-03-5 2-butyl-4-chloro-1,6-dihydro-6-methyl-1-<<2'-<1-(triphenylmethyl)tetrazole-5-yl><1,1'-biphenyl>-4-yl>methyl>pyrimidine-5-carboxylic acid, diphenylmethyl ester 
• 150058-31-4 methyl 2-ethoxy-1-<<2'-biphenyl-4-yl>methyl>-1H-benzimidazole-6-carboxylate 
• 150058-30-3 methyl 2-ethoxy-1-<<2'-biphenyl-4-yl>methyl>-1H-benzimidazole-5-carboxylate 
• 150058-29-0 methyl 2-ethoxy-1-<<2'-biphenyl-4-yl>methyl>-1H-benzimidazole-4-carboxylate 
• 136285-63-7 5-Chloro-3-nitro-2-{pentanoyl-[2'-(1-trityl-1H-tetrazol-5-yl)-biphenyl-4-ylmethyl]-amino}-benzoic acid methyl ester 
• 136285-59-1 6-Methyl-3-nitro-2-{pentanoyl-[2'-(1-trityl-1H-tetrazol-5-yl)-biphenyl-4-ylmethyl]-amino}-benzoic acid ethyl ester 
• 1062320-30-2 (1,1-Dimethyl-2-{2-oxo-1-[2'-(1-trityl-1H-tetrazol-5-yl)-biphenyl-4-ylmethyl]-1,2,3,4-tetrahydro-quinolin-3-ylcarbamoyl}-ethyl)-carbamic acid tert-butyl ester 
• 1059656-14-2 (1,1-Dimethyl-2-{2-oxo-1-[2'-(1-trityl-1H-tetrazol-5-yl)-biphenyl-4-ylmethyl]-1,2,3,4,5,6-hexahydro-benzo[b]azocin-3-ylcarbamoyl}-ethyl)-carbamic acid tert-butyl ester 
• 1026422-80-9 3-<(tert-butoxycarbonyl)amino>-3-methyl-N-<2,3,4,5-tetrahydro-2-oxo-1-<<2'-<1,1'-biphenyl>-4-yl>methyl>-1H-1-benzazepin-3(R)-yl>butanamide 

Relevant articles and documents

Method for synthesizing high-purity sartan side chain TTBB

The invention discloses a method for synthesizing high-purity sartan side chain TTBB. The method comprises the following steps: taking 4-methyl-2-cyanobiphenyl as a starting material; under a catalytic action of lewis acid triethylamine hydrochloride, carrying out cyclization reaction on the 4-methyl-2-cyanobiphenyl and sodium azide to generate a 5-[2-(4'-methyldiphenyl)]tetrazole compound; reacting the 5-[2-(4'-methyldiphenyl)] tetrazole compound with triphenylchloromethane under an alkaline condition to generate an N-(triphenylmethyl)-5-(4'-methylbiphenyl-2-yl)tetrazole compound; reacting togenerate a mixture of a compound TTBB and a compound Br-TTBB under the action of bromine-containing substances; promoting the compound Br-TTBB to be converted into the compound TTBB under the actionof diethyl phosphite by the mixture, thus finally obtaining the high-purity sartan side chain TTBB. The synthetic process disclosed by the invention has the advantages of better economical property, environment friendliness, high efficiency, simplicity and convenience; the mode of improving the purity of a target product through recrystallization for multiple times by adopting a conventional method is avoided.

Method for tubular reaction preparation of substituted benzylically brominated methyl biphenyl and reaction device of method

The invention discloses a method for tubular reaction preparation of substituted benzylically brominated methyl biphenyl and a reaction device of the method. According to the method, substituted methyl biphenyl is taken as a raw material and bromine is taken as a bromination reagent. The reaction materials are continuously fed into a high-efficiency mixer for mixing through a liquid conveying pump, and the formed mixture enters a reactor in a water bath for a reaction, after the reaction is finished, the reaction system enters a receiving tank, a reducing agent is added to the receiving tank for quenching, liquid separation is carried out, anhydrous sodium sulfate is added into the organic phase, suction filtration is performed, the organic phase is subjected to reduced-pressure concentration for solvent removal, a solvent is added for recrystallization, suction filtration is performed, and the filter cake is dried to obtain a pure product namely the substituted benzylically brominatedmethyl biphenyl. The method of the invention is simple and convenient to control, high in safety, less in generation of by-products and convenient for post-processing, a small trial process can be directly used for amplified production. The method meets the requirements of green chemistry and has a certain industrial application value.

1,(3,)5-substituted imidazoles, useful in the treatment of hypertension and methods for their preparation

The present invention provides novel 1,5 and 1,3,5-substituted imidazole compounds in hydrophilic or lipophilic form, which are useful as angiotensin II ATI receptor antagonists suitable for transdermal delivery. The invention also provides pharmaceutical compositions containing such compounds, processes and intermediates for preparing compounds and their use in methods of treating hypertension and cardiovascular diseases.

Bacterial Peptide Deformylase Inhibition of Tetrazole-Substituted Biaryl Acid Analogs: Synthesis, Biological Evaluations, and Molecular Docking Study

The synthesis and screening of tetrazole-substituted biaryl acid analogs 7a–l as bacterial peptide deformylase (PDF) enzyme inhibitors is reported. The compounds 7e (IC50 value = 5.50 μM) and 7g (IC50 value = 7.25 μM) showed good PDF inhibition activity. The compounds 7e (MIC range = 10.75–11.66 μg/mL) and 7g (MIC range = 8.91–12.83 μg/mL) also showed potent antibacterial activity when compared with the standard ciprofloxacin (MIC range = 25–50 μg/mL). Thus, the active derivatives were not only potent PDF enzyme inhibitors but also efficient antibacterial agents. In order to gain more insight into the binding mode of the compounds with the PDF enzyme, the most active compounds 7e and 7g, the moderately active compound 7k, and the least active compound 7h were docked against the PDF enzyme of Escherichia coli. The docking study of the most active compounds 7e and 7g against the PDF enzyme exhibited good binding properties. Hence, we believe our synthesized compounds 7a–l could serve as reservoir for bacterial PDF inhibitor development.

A process for the preparation of olmesartan

The invention discloses a preparation method of Olmesartan Medoxomil. The method is used for synthesizing an important intermediate 4-[2-(2-triphenylmethyl tetrazole-5-yl) phenyl] benzyl bromide (a compound III) so as to prepare the compound Olmesartan Medoxomil. The method is high in yield, easy to separate and purify, simple to operate and suitable for industrial production.

Preparation of 5 - (4 the [...] -bromo methyl-2-biphenyl) - 1-trityl tetrazazole method

The invention discloses a method for preparing 5-(4'-bromomethyl-2-biphenyl)-1-triphenyl methyl tetrazole. According to the method, 2-cyano biphenyl is used for replacing 2-cyano 4'-methyl biphenyl in the conventional process and is used as a starting material, and a target product, the 5-(4'-bromomethyl-2-biphenyl)-1-triphenyl methyl tetrazole, is obtained by means of hydroxymethylation, cyclization, protection, and substitution reaction. The method has the advantages of low cost of the raw materials, convenience for recovery of solvent, less comprehensive pollution and the like and is suitable for industrialized production.

Synthesis of new biphenyl-substituted quinoline derivatives, preliminary screening and docking studies

New quinoline derivatives containing biphenyl ring were synthesized and characterized by IR, 1H NMR and mass spectral studies. The synthesized compounds were screened for antimicrobial, anthelmintic activities as well as free radical scavenging property against the DPPH radical. The minimum inhibition concentration values showed promising inhibiting activity and are potent biological agents. The compounds showed minimum binding energy towards ?-tubulin. The compounds 11a, 11c, 13c and 13d have good affinity towards the active pocket and may be considered as a good inhibitor of β-tubulin. Indian Academy of Sciences.

Synthesis of new biphenyl-substituted quinoline derivatives, preliminary screening and docking studies

New quinoline derivatives containing biphenyl ring were synthesized and characterized by IR, 1H NMR and mass spectral studies. The synthesized compounds were screened for antimicrobial, anthelmintic activities as well as free radical scavenging property against the DPPH radical. The minimum inhibition concentration values showed promising inhibiting activity and are potent biological agents. The compounds showed minimum binding energy towards β-tubulin. The compounds 11a, 11c, 13c and 13d have good affinity towards the active pocket and may be considered as a good inhibitor of β-tubulin.

Synthesis and evaluation of quinazoline derivatives as phosphodiesterase 7 inhibitors

The latest scientific findings concerning PDE7 and PDE4 inhibition suggest that selective small-molecule inhibitors of both enzymes could provide a novel approach to treat a variety of immunological diseases. In this context, we describe a new series of quinazoline derivatives from quinazolin-4-thiones which include a substituted biphenyl fragment. Some of these compounds show inhibitory potencies at sub-micromolar levels against the catalytic domain of PDE7.

N-ARYLYLMETHYLINDAZOLE MODULATORS OF PPARG

The invention provides molecular entities that bind with high affinity to PPARG (PPARy), inhibit cdJk5-mediated phosphorylation of PP ARG, but do not exert an agonistic effect on PPARG. Compounds of the invention can be used for treatment of conditions in patients wherein PPARG plays a role, such as diabetes or obesity. Methods of preparation of the compounds, bioassay methods for evaluating compounds of the invention as non-agonistic PPARG binding compounds, and pharmaceutical compositions are also provided.